2022³âµµ Á¦ 108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ ÃÖ¿ì¼öÆ÷½ºÅÍ»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù.
- ¸ðüžÆÀÇÇÐ
-
- ¼ö»óÀÚ : ÀÌÈ«¿¬(°¡Å縯ÀÇ´ë)
- ¼ö»ó³í¹® : Risk factors for high neonatal serum magnesium concentrations in prenatal maternal magnesium therapy
- ºÎÀÎÁ¾¾çÇÐ
-
- ¼ö»óÀÚ : ÀÌ¿µÁÖ(¿¬¼¼ÀÇ´ë)
- ¼ö»ó³í¹® : Initial good response to neoadjuvant chemotherapy was not related to survival benefit of ovarian cancer in the maintenance therapy era
- »ý½Ä³»ºÐºñÇÐ
-
- ¼ö»óÀÚ : ±è»óÈ(¿¬¼¼ÀÇ´ë)
- ¼ö»ó³í¹® : Comparison of the impact of methotrexate sclerotherapy and surgery on the ovarian reserve in ovarian endometrioma patients
- ÀϹݺÎÀΰúÇÐ
-
- ¼ö»óÀÚ : Â÷Áö¹Î(°¡Å縯ÀÇ´ë)
- ¼ö»ó³í¹® : Àڱ󻸷Áõ À¯µµ ¸¶¿ì½º ¸ðµ¨À» ÀÌ¿ëÇÑ Uterine residual NK cellÀÇ Æò°¡